ALKERMES | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
ALKERMES USD 1.51B 46.61M 2025-03
Amgen USD 6.21B 330M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
J&J USD 78.11B 6.62B 2025-03
Malin Corporation EUR 118.2M 8.7M 2024-06
Merck USD 48.34B 2.02B 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Otsuka Holdings JPY 2.65T 85.39B 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



ALKERMES Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.